Fighting Cancer and Infectious Diseases KUPANDO is a pioneering Berlin-based biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity. Our Mission is … to provide, not only a safe but also affordable, immunotherapy to cancer patients, and to develop immunostimulatory agents with the means to prevent infectious diseases. TLR 4/7 AGONIST Drug Candidate […]
Location: Germany, Brandenburg, Schönefeld
Employees: 1-10
Total raised: $14.16M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | BFB Brande... | brandenbur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.10.2022 | Series A | $14.16M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 01.10.2022 | Kupando raises €13 million in Series A funding round | Potsdam/Schönefeld/Berlin, 26. September 2022 – Kupando, a pioneering biopharmaceutical company de... | brandenbur... |
| 26.09.2022 | Kupando Raises €13M in Series A Funding | Kupando, a Schoenefeld, Germany-based biopharmaceutical company developing TLR 4/7 agonists that sti... | finsmes.co... |
| - | Kupando raises €13 million in Series A funding round | Potsdam/Schönefeld/Berlin, 26. September 2022 – Kupando, a pioneering biopharmaceutical company de... | brandenbur... |